Fibrinolytic therapy in suspected acute myocardial infarction

The Lancet

Volumn 343, Issue 8902, 1994, Pages 912-913

  Fath Ordoubadi, F ^a   Beatt, Kj ^a   Davis, R C ^b   Carlsson, Jörg ^c   Rahlf, Günther ^c   Tebbe, Ulrich ^c  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^b Department of Microbiology   (United Kingdom)

^c KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT; STREPTOKINASE;

ACUTE HEART INFARCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MEDICAL DECISION MAKING; PATIENT CARE; PRIORITY JOURNAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; MORTALITY; NOTE; AGED; CASE REPORT; FATALITY; FEMALE; HEART RUPTURE; RISK FACTOR;

HUMAN; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY; AGED; CASE REPORT; FATAL OUTCOME; FEMALE; HEART RUPTURE, POST-INFARCTION; RISK FACTORS; STREPTOKINASE;

EID: 0028344278     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(94)90029-9     Document Type: Letter

References (9)

1. Timing of coronary recanalization: Paradigms, paradoxes, and pertinence
2. The Myocardial Infarction Triage and Intervention Trial. Prehospital-initiated vs hospital-initiated thrombolytic therapy
3. Prehospital thrombolysis: beneficial effects of very early treatment on infarct size and left ventricular function
4. The effects of tissue plasminogen activator streptokinase or both on coronary-artery patency ventricular function and survival after acute myocardial infarction
5. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction ISIS-1
6. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients.
7. How sound is the evidence that thrombolysis increases the risk of cardiac rupture?
8. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis
9. Status of the myocardium and infarct-related coronary artery in 19 necropsy patients with acute recanalization using pharmacologic (streptokinase, r-tissue plasminogen activator), mechanical (PTCA) or combined types of reperfusion therapy